Ardelyx is a publicly traded commercial biopharmaceutical company founded with a mission to discover, develop and commercialize innovative first-in-class medicines that meet significant unmet medical needs. Ardelyx has two commercial products approved in the United States, IBSRELA® (tenapanor) and XPHOZAH® (tenapanor). Ardelyx has agreements for the development and commercialization of tenapanor outside of the U.S. Kyowa Kirin commercializes PHOZEVEL® (tenapanor) for hyperphosphatemia in Japan. A New Drug Application for tenapanor for hyperphosphatemia has been approved in China with Fosun Pharma. Knight Therapeutics commercializes IBSRELA in Canada. The Senior SAS Programmer is responsible for applying advanced programming techniques to support the development and validation of statistical programs to be used for monitoring, analyzing, and reporting of Ardelyx’ clinical trial data for regulatory submissions and publications across multiple disease areas at Ardelyx. This position works closely with Biostatisticians, Data Managers, Clinical Trial Managers, and if necessary, Contract Research Organizations (CROs) and/or SAS programming consultants, to meet project deliverables and timelines for clinical data monitoring, analyzing, and reporting.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Mid Level